rs10205042

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000091.5(COL4A3):​c.1195C>T​(p.Leu399Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.751 in 1,613,536 control chromosomes in the GnomAD database, including 456,799 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. L399L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.73 ( 40860 hom., cov: 32)
Exomes 𝑓: 0.75 ( 415939 hom. )

Consequence

COL4A3
NM_000091.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: -0.664

Publications

29 publications found
Variant links:
Genes affected
COL4A3 (HGNC:2204): (collagen type IV alpha 3 chain) Type IV collagen, the major structural component of basement membranes, is a multimeric protein composed of 3 alpha subunits. These subunits are encoded by 6 different genes, alpha 1 through alpha 6, each of which can form a triple helix structure with 2 other subunits to form type IV collagen. This gene encodes alpha 3. In the Goodpasture syndrome, autoantibodies bind to the collagen molecules in the basement membranes of alveoli and glomeruli. The epitopes that elicit these autoantibodies are localized largely to the non-collagenous C-terminal domain of the protein. A specific kinase phosphorylates amino acids in this same C-terminal region and the expression of this kinase is upregulated during pathogenesis. This gene is also linked to an autosomal recessive form of Alport syndrome. The mutations contributing to this syndrome are also located within the exons that encode this C-terminal region. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jun 2010]
MFF-DT (HGNC:41067): (MFF divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 2-227263824-C-T is Benign according to our data. Variant chr2-227263824-C-T is described in ClinVar as Benign. ClinVar VariationId is 254976.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.664 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.856 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000091.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A3
NM_000091.5
MANE Select
c.1195C>Tp.Leu399Leu
synonymous
Exon 21 of 52NP_000082.2Q01955-1
MFF-DT
NR_102371.1
n.1486+845G>A
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A3
ENST00000396578.8
TSL:1 MANE Select
c.1195C>Tp.Leu399Leu
synonymous
Exon 21 of 52ENSP00000379823.3Q01955-1
MFF-DT
ENST00000439598.6
TSL:1
n.1486+845G>A
intron
N/A
COL4A3
ENST00000871618.1
c.1195C>Tp.Leu399Leu
synonymous
Exon 21 of 52ENSP00000541677.1

Frequencies

GnomAD3 genomes
AF:
0.732
AC:
111237
AN:
151988
Hom.:
40817
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.673
Gnomad AMI
AF:
0.574
Gnomad AMR
AF:
0.769
Gnomad ASJ
AF:
0.638
Gnomad EAS
AF:
0.878
Gnomad SAS
AF:
0.817
Gnomad FIN
AF:
0.800
Gnomad MID
AF:
0.623
Gnomad NFE
AF:
0.741
Gnomad OTH
AF:
0.686
GnomAD2 exomes
AF:
0.768
AC:
191130
AN:
248780
AF XY:
0.766
show subpopulations
Gnomad AFR exome
AF:
0.670
Gnomad AMR exome
AF:
0.846
Gnomad ASJ exome
AF:
0.637
Gnomad EAS exome
AF:
0.884
Gnomad FIN exome
AF:
0.798
Gnomad NFE exome
AF:
0.737
Gnomad OTH exome
AF:
0.744
GnomAD4 exome
AF:
0.753
AC:
1100520
AN:
1461430
Hom.:
415939
Cov.:
48
AF XY:
0.753
AC XY:
547225
AN XY:
727030
show subpopulations
African (AFR)
AF:
0.667
AC:
22329
AN:
33468
American (AMR)
AF:
0.837
AC:
37436
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.642
AC:
16783
AN:
26132
East Asian (EAS)
AF:
0.868
AC:
34447
AN:
39690
South Asian (SAS)
AF:
0.806
AC:
69531
AN:
86242
European-Finnish (FIN)
AF:
0.795
AC:
42430
AN:
53380
Middle Eastern (MID)
AF:
0.649
AC:
3744
AN:
5768
European-Non Finnish (NFE)
AF:
0.745
AC:
828511
AN:
1111656
Other (OTH)
AF:
0.750
AC:
45309
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
14398
28797
43195
57594
71992
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20340
40680
61020
81360
101700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.732
AC:
111337
AN:
152106
Hom.:
40860
Cov.:
32
AF XY:
0.736
AC XY:
54731
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.673
AC:
27914
AN:
41478
American (AMR)
AF:
0.769
AC:
11772
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.638
AC:
2215
AN:
3470
East Asian (EAS)
AF:
0.878
AC:
4546
AN:
5180
South Asian (SAS)
AF:
0.816
AC:
3930
AN:
4814
European-Finnish (FIN)
AF:
0.800
AC:
8462
AN:
10574
Middle Eastern (MID)
AF:
0.633
AC:
186
AN:
294
European-Non Finnish (NFE)
AF:
0.741
AC:
50343
AN:
67972
Other (OTH)
AF:
0.685
AC:
1447
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1552
3105
4657
6210
7762
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
850
1700
2550
3400
4250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.720
Hom.:
18021
Bravo
AF:
0.726
Asia WGS
AF:
0.808
AC:
2813
AN:
3478
EpiCase
AF:
0.713
EpiControl
AF:
0.718

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
not specified (7)
-
-
2
Alport syndrome (2)
-
-
2
not provided (2)
-
-
1
Autosomal dominant Alport syndrome (1)
-
-
1
Autosomal recessive Alport syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.64
CADD
Benign
1.9
DANN
Benign
0.76
PhyloP100
-0.66
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10205042; hg19: chr2-228128540; COSMIC: COSV108247715; COSMIC: COSV108247715; API